Patents by Inventor Robert T. McCluskey

Robert T. McCluskey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5200319
    Abstract: A purified protein (p29) capable of binding auto-antibodies present in the sera of individuals suffering from Wegener's granulomatosis. The invention also features a monoclonal antibody against the p29 protein and methods of diagnosing Wegener's granulomatosis, pauci-immune necrotizing and/or crescentic glomerulonephritis, and other conditions associated with glomerulonephritis.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: April 6, 1993
    Assignee: The General Hospital Corporation
    Inventors: M. Amin Arnaout, Robert T. McCluskey, John L. Niles
  • Patent number: 5091303
    Abstract: A purified protein (p29) capable of binding autoantibodies present in the sera of individuals suffering from Wegener's granulomatosis. The invention also features a monoclonal antibody against the p29 protein and methods of diagnosing Wegener's granulomatosis.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: February 25, 1992
    Assignee: The General Hospital Corporation
    Inventors: M. Amin Arnaout, Robert T. McCluskey, John L. Niles